Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Double Blind, Placebo Controlled, Randomized, > Multicenter Study With AVR118 Solution in Patients With Advanced > Malignancies Who Are Not Candidates for Curative Chemotherapy.

NCT00127517 is registered in ClinicalTrials.gov with Advanced Viral Research Corp as lead sponsor.

NCT NCT00127517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00127517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Double Blind, Placebo Controlled, Randomized, > Multicenter Study With AVR118 Solution in Patients With Advanced > Malignancies Who Are Not Candidates for Curative Chemotherapy.
Lead sponsor
Advanced Viral Research Corp
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2005
Completion date
August 31, 2006
Enrollment
Not reported
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer